NO945022L - Nikotinsyreestere - Google Patents

Nikotinsyreestere

Info

Publication number
NO945022L
NO945022L NO945022A NO945022A NO945022L NO 945022 L NO945022 L NO 945022L NO 945022 A NO945022 A NO 945022A NO 945022 A NO945022 A NO 945022A NO 945022 L NO945022 L NO 945022L
Authority
NO
Norway
Prior art keywords
saturated
carbon atoms
acid esters
nicotinic acid
compounds
Prior art date
Application number
NO945022A
Other languages
English (en)
Other versions
NO302945B1 (no
NO945022D0 (no
Inventor
Torbjorn Lundstedt
Lisbeth Abramo
Anders Bjork
Goran Pettersson
Gunnar Andersson
Curt Nordvi
Jin Chang Wu
Catarina Ludwig
Elisabeth Seifert
Arne Nilsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO945022D0 publication Critical patent/NO945022D0/no
Publication of NO945022L publication Critical patent/NO945022L/no
Publication of NO302945B1 publication Critical patent/NO302945B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO945022A 1992-06-25 1994-12-23 Nikotinsyreestere NO302945B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201956A SE9201956D0 (sv) 1992-06-25 1992-06-25 Novel nicotinicacid esters
PCT/SE1993/000565 WO1994000434A1 (en) 1992-06-25 1993-06-23 Novel nicotinic acid esters

Publications (3)

Publication Number Publication Date
NO945022D0 NO945022D0 (no) 1994-12-23
NO945022L true NO945022L (no) 1995-02-13
NO302945B1 NO302945B1 (no) 1998-05-11

Family

ID=20386602

Family Applications (1)

Application Number Title Priority Date Filing Date
NO945022A NO302945B1 (no) 1992-06-25 1994-12-23 Nikotinsyreestere

Country Status (27)

Country Link
US (1) US5658910A (no)
EP (2) EP0673368B1 (no)
JP (1) JP3306827B2 (no)
KR (1) KR100302216B1 (no)
CN (1) CN1085981C (no)
AT (2) ATE209634T1 (no)
AU (1) AU681346B2 (no)
BG (1) BG62000B1 (no)
CA (1) CA2139112C (no)
CZ (1) CZ281975B6 (no)
DE (2) DE69331234T2 (no)
DK (1) DK0673368T3 (no)
EE (1) EE03122B1 (no)
ES (1) ES2169044T3 (no)
FI (1) FI107151B (no)
HU (2) HU220613B1 (no)
IL (1) IL106135A (no)
NO (1) NO302945B1 (no)
NZ (1) NZ253823A (no)
PH (1) PH31417A (no)
PT (1) PT673368E (no)
RO (1) RO115725B1 (no)
RU (1) RU2127732C1 (no)
SE (1) SE9201956D0 (no)
SK (1) SK279393B6 (no)
WO (1) WO1994000434A1 (no)
ZA (1) ZA934596B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド グリコーゲンシンターゼキナーゼ３のインヒビター
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
BR112020022790A2 (pt) * 2018-05-09 2021-02-02 Lg Chem, Ltd novo composto que exibe atividade inibitória de enteropeptidase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
SE9202265D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel- pyridyl and pyrimidylpiperazine derivatives

Also Published As

Publication number Publication date
ZA934596B (en) 1994-02-14
HU210875A9 (en) 1995-08-28
SK279393B6 (sk) 1998-11-04
SK158594A3 (en) 1995-07-11
KR950702186A (ko) 1995-06-19
CA2139112C (en) 2006-03-21
JP3306827B2 (ja) 2002-07-24
PT673368E (pt) 2002-05-31
US5658910A (en) 1997-08-19
DE69331234D1 (de) 2002-01-10
SE9201956D0 (sv) 1992-06-25
JPH07508517A (ja) 1995-09-21
CN1085981C (zh) 2002-06-05
CZ281975B6 (cs) 1997-04-16
RO115725B1 (ro) 2000-05-30
AU4519393A (en) 1994-01-24
RU94046310A (ru) 1996-10-27
PH31417A (en) 1998-10-29
HU9403786D0 (en) 1995-02-28
DE69333655D1 (de) 2004-11-11
DK0673368T3 (da) 2002-03-18
EP1120410A1 (en) 2001-08-01
IL106135A0 (en) 1993-10-20
FI946085A (fi) 1994-12-23
ATE209634T1 (de) 2001-12-15
KR100302216B1 (ko) 2001-11-22
RU2127732C1 (ru) 1999-03-20
WO1994000434A1 (en) 1994-01-06
DE69331234T2 (de) 2002-08-08
EP0673368A1 (en) 1995-09-27
EP1120410B1 (en) 2004-10-06
NO302945B1 (no) 1998-05-11
EP0673368B1 (en) 2001-11-28
FI107151B (fi) 2001-06-15
CA2139112A1 (en) 1994-01-06
HUT71406A (en) 1995-11-28
FI946085A0 (fi) 1994-12-23
NO945022D0 (no) 1994-12-23
HU220613B1 (hu) 2002-03-28
ES2169044T3 (es) 2002-07-01
CZ327494A3 (en) 1995-09-13
AU681346B2 (en) 1997-08-28
ATE278671T1 (de) 2004-10-15
EE03122B1 (et) 1998-10-15
IL106135A (en) 1999-01-26
NZ253823A (en) 1996-01-26
CN1086811A (zh) 1994-05-18
BG62000B1 (bg) 1998-12-30
BG99289A (bg) 1995-09-29

Similar Documents

Publication Publication Date Title
BG105254A (en) Heterocyclic compounds as inhibitors of rotamase enzymes
ATE136882T1 (de) Carbamidsäureester-derivate, mittel und herstellungsverfahren
NZ336202A (en) Pure enantiomer aryl-cycloalkyl-hydroxycarboxylic acid esters and use in treating smooth muscle spasms and respiritory diseases
ATE261919T1 (de) Verwendung von pyrazolderivaten als nitrifikationsinhibitoren
DE69133299D1 (de) Aminosulfonylcarbamate
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
FI931765A0 (fi) Steroidderivat foer behandling av prostatahypertrofi, deras framstaellning och anvaendningar
NO945022D0 (no) Nikotinsyreestere
DE3867652D1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
IE893211L (en) Benzoxazepinone Process
BR8502885A (pt) Processo para preparar acido azetidino-3-carboxilico,seus derivados e usos
NO179004C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazolderivater
DE68908761D1 (de) Monopersulfate von stickstoffenthaltenden heterocyclischen Polypercarbonsäuren.
FR2694557B1 (fr) Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
GEP19971013B (en) Novel pyridyl and pyrimidyl derivatives process for preparing thereof, and treatment method for mental disorder
DE69333903D1 (de) Optisch aktive 1-Phenylpyrrolidonderivate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees